Expression of bcl-2 correlates with poor prognosis and modulates migration of nasopharyngeal carcinoma cells

Clinica Chimica Acta

Volumn 411, Issue 5-6, 2010, Pages 400-405

  Chen, Mu Kuan ^a,b,c   Yang, Shun Fa ^c   Lai, Jui Chung ^a   Yeh, Kun Tu ^a   Yang, Jia Sin ^c   Chen, Li Sheng ^a   Chen, Hui Chuan ^d  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b MINGDAO UNIVERSITY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d PROVIDENCE UNIVERSITY   (Taiwan)

Author keywords

Bcl 2; Inhibitor; Matrix metalloproteinases; Nasopharyngeal carcinoma; Prognosis

Indexed keywords

2 AMINO 6 BROMO 4 (1 CYANO 2 ETHOXY 2 OXOETHYL) 4H CHROMENE 3 CARBOXYLIC ACID ETHYL ESTER; GELATINASE A; PROTEIN BCL 2;

ADULT; ARTICLE; CANCER CELL; CANCER CLASSIFICATION; CANCER STAGING; CANCER SURVIVAL; CELL MIGRATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GENE FUNCTION; HUMAN; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; METASTASIS; MIGRATION INHIBITION; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BENZOPYRANS; CELL MOVEMENT; DISEASE-FREE SURVIVAL; DOSE-RESPONSE RELATIONSHIP, RADIATION; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MATRIX METALLOPROTEINASE 2; MIDDLE AGED; NASOPHARYNGEAL NEOPLASMS; NEOPLASM STAGING; NITRILES; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTO-ONCOGENE PROTEINS C-BCL-2; STRUCTURE-ACTIVITY RELATIONSHIP; TUMOR CELLS, CULTURED;

EID: 74849087093     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2009.12.010     Document Type: Article

References (31)

1. Cho W.C. Nasopharyngeal carcinoma: molecular biomarker discovery and progress. Mol Cancer 6 (2007) 1
2. Du Z.M., Hu C.F., Shao Q., Huang M.Y., Kou C.W., Zhu X.F., et al. Upregulation of caveolin-1 and CD147 expression in nasopharyngeal carcinoma enhanced tumor cell migration and correlated with poor prognosis of the patients. Int J Cancer 125 (2009) 1832-1841
3. Zhou J., Wang S., Lu J., Li J., and Ding Y. Over-expression of phosphatase of regenerating liver-3 correlates with tumor progression and poor prognosis in nasopharyngeal carcinoma. Int J Cancer 124 (2009) 1879-1886
4. Chen M.K., Chen T.H.H., Liu J.P., Chang C.C., and Chie W.C. A better prognosis prediction on patients with nasopharyngeal carcinoma by using primary tumor volumes. Cancer 100 (2004) 2160-2166
5. Chang C.C., Chen M.K., Liu M.T., and Wu H.K. The effect of primary tumor volumes in advanced T-staged nasopharyngeal tumors. Head Neck 24 (2002) 940-946
6. Chen M.K., Lai J.C., Chang C.C., Chang J.H., Chang Y.J., and Chen H.C. Prognostic impact of bcl-2 expression on advanced nasopharyngeal carcinoma. Head Neck (2008) 1052-1057
7. Yang S.F., Yang W.E., Kuo W.H., Chang H.R., Chu S.C., and Hsieh Y.S. Antimetastatic potentials of flavones on oral cancer cell via an inhibition of matrix-degrading proteases. Arch Oral Biol 53 (2008) 287-294
8. Yang S.F., Liu Ch.u.S.C., SJ C.Y.C., Chang Y.Z., and Hsieh Y.S. Antimetastatic activities of Selaginella tamariscina (Beauv.) on lung cancer cells in vitro and in vivo. J Ethnopharmacol 110 (2007) 483-489
9. Hwang J.H., Lim S.C., Kim Y.C., Park K.O., Ahn S.J., and Chung W.K. Apoptosis and bcl-2 expression as predictors of survival in radiation-treated non-small cell lung cancer. Int J Radiat Oncol Biol Phys. 50 (2001) 13-18
10. Jain D., Srinivasan R., Patel F.D., and Gupta S.K. Evaluation of p53 an bcl-2 expression as prognostic marker in invasive cervical carcinoma stage IIb/III patients treated by radiotherapy. Gynecol Oncol. 88 (2003) 22-28
11. Scherr D.S., Vaughan Jr. E.D., Wei J., Chung M., Felsen D., Allbright R., et al. Bcl-2 and p53 expression in clinically localized prostate cancer predicts response to external beam radiotherapy. J Urol. 162 (1999) 12-17
12. McDonnell T.J., Troncoso P., Brisbay S.M., Logothetis C., Chung L.W., Hsieh J.T., et al. Expression of the protooncogene bcl-2 in the prostate and its association with emergence of androgen-independent prostate cancer. Cancer Res. 52 (1992) 6940-6944
13. Sheu L.F., Chen A., Meng C.L., Ho K.C., Lin F.G., and Lee W.H. Analysis of bcl-2 expression in normal, inflamed, dysplastic nasopharyngeal epithelia, and nasopharyngeal carcinoma: association with p53 expression. Human Pathol 28 (1997) 556-562
14. Vera-Sempere F.J., Burgos J.S., Botella M.S., and Morera C. Immunohistochemical expression of bcl-2 oncoprotein in EBV-associated nasopharyngeal carcinoma correlated to histologic type and survival. Histol Histopathol. 12 (1997) 9-18
15. Sarac S., Akyol M.U., Kanbur B., Poyraz A., Akyol G., Yilmaz T., et al. Bcl-2 and LMP1 expression in nasopharyngeal carcinomas. Am J Otolaryngol. 22 (2001) 377-382
16. Khabir A., Ghorbel A., Daoud J., Frikha M., Drira M.M., Laplanche A., et al. Similar bcl-x but different bcl-2 levels in the two age group of North African nasopharyngeal carcinomas. Cancer Detect Prev. 27 (2003) 250-255
17. Sheu L.F., Chen A., Lee H.S., Hsu H.Y., and Yu D.S. Cooperative interactions among p53, bcl-2 and Epstein-Barr virus latent membrane protein 1 in nasopharyngeal carcinoma cells. Pathol Int. 54 (2004) 475-485
18. Colombel M., Symmans F., Gil S., O'Toole K.M., Chopin D., Benson M., et al. Detection of the apoptosis-suppressing oncoprotein bcl-2 in hormone-refractory human prostate cancer. Am J Pathol. 143 (1993) 390-400
19. Michaud W.A., Nichols A.C., Mroz E.A., Faquin W.C., Clark J.R., Begum S., et al. Bcl-2 blocks cisplatin-induced apoptosis and predicts poor outcome following chemoradiation treatment in advanced oropharyngeal squamous cell carcinoma. Clin Cancer Res 15 (2009) 1645-1654
20. Doglioni C., Dei Tos A.P., Laurino L., Chiarelli C., Barbareschi M., and Viale G. The prevalence of bcl-2 immunoreactivity in breast carcinomas and its clinicopathological correlates, with particular reference to oestrogen receptor status. Virchows Arch. 424 (1994) 47-51
21. Pilotti S., Collini P., Rilke F., Cattoretti G., Del Bo R., and Pierotti M.A. Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol. 172 (1994) 337-342
22. Pezzela F., Turley H., Kuzu I., Tungekar M.F., Dunnill M.S., Pierce C.B., et al. Bcl-2 protein in non-small cell lung carcinoma. N Engl J Med. 329 (1993) 690-694
23. Choy H., and Kim D.W. Chemotherapy and irradiation interaction. Semin Oncol. 30 (2003) 3-10
24. Jiang S.X., Sato T., Kuwao S., and Kameya T. Expression of bcl-2 oncogene protein is prevalent in small cell lung carcinomas. J Pathol. 177 (1995) 135-138
25. Rosser C.J., Tanaka M., Pisters L.L., Tanaka N., Levy L.B., Hoover D.C., et al. Adenoviral-mediated PTEN transgene expression sensitizes Bcl-2-expression prostate cancer cells to radiation. Cancer Gene Ther. 11 (2004) 273-279
26. Chen M., Quintans J., Fuks Z., Thompson C., Kufe D.W., and Weichselbaum R.R. Suppression of Bcl-2 messenger RNA production may mediate apoptosis after ionizing radiation tumor necrosis factor alpha, and ceramide. Cancer Res. 55 (1995) 991-994
27. Stacker S.A., Achen M.G., Jussila L., Baldwin M.E., and Alitalo K. Lymphangiogenesis and cancer metastasis. Nat Rev Cancer 2 (2002) 573-583
28. Tryggvason K., Hoyhtya M., and Salo T. Proteolytic degradation of extracellular matrix in tumor invasion. Biochim Biophys Acta 907 (1987) 191-217
29. Libra M., Scalisi A., Vella N., Clementi S., Sorio R., Stivala F., et al. Uterine cervical carcinoma: role of matrix metalloproteinases. Int J Oncol 34 (2009) 897-903
30. Pepper M.S. Role of the matrix metalloproteinase and plasminogen activator-plasmin systems in angiogenesis. Arterioscler Thromb Vasc Biol 21 (2001) 1104-1117
31. Nyberg P., Moilanen M., Paju A., Sarin A., Stenman U.H., Sorsa T., et al. MMP-9 activation by tumor trypsin-2 enhances in vivo invasion of human tongue carcinoma cells. J Dent Res 81 (2002) 831-835